Posts

AI Endoscopy Consensus Statement Focuses on Privacy, Bias

The World Endoscopy Organization consensus statement offers guidance to support the safe and responsible integration of AI endoscopy tools into clinical practice. Medscape Medical News source https://www.medscape.com/viewarticle/ai-endoscopy-consensus-statement-focuses-privacy-bias-2025a1000yv4?src=rss

Methadone, Buprenorphine May Lower Opioid Overdose Risk

Medication use for opioid use disorder has increased but remains low, and methadone and buprenorphine are linked to reduced risk for opioid overdose, a new study shows. Medscape Medical News source https://www.medscape.com/viewarticle/methadone-buprenorphine-may-lower-opioid-overdose-risk-2025a1000yuq?src=rss

Heart Blocks During vs After TAVR Show Distinct Patterns

Atrioventricular blocks occurring during transcatheter aortic valve replacement differ from those occurring after the procedure, with distinct predictors for each. Medscape Medical News source https://www.medscape.com/viewarticle/heart-blocks-during-vs-after-tavr-show-distinct-patterns-2025a1000ypp?src=rss

Child-Friendly Forms of Drugs Limited, Alternatives Missing

Despite increased labeling of drugs with pediatric information, most medicines remain available only as pills meant for adults, and alternatives are often missing when child friendly versions are discontinued. Medscape Medical News source https://www.medscape.com/viewarticle/child-friendly-forms-drugs-limited-alternatives-missing-2025a1000ypl?src=rss

Infant Hydrocortisone Shows No Developmental Harm Later

Neonatal hydrocortisone vs placebo for premature infants at risk for bronchopulmonary dysplasia shows no benefit or harm and no difference in functional impairment by the time they reach kindergarten. Medscape Medical News source https://www.medscape.com/viewarticle/infant-hydrocortisone-shows-no-developmental-harm-later-2025a1000ykp?src=rss

FDA OKs First Cell Therapy for Severe Aplastic Anemia

The approval marks the second indication for omidubicel, following its 2023 nod for patients with hematologic malignancies set to undergo cord blood transplantation. Medscape Medical News source https://www.medscape.com/viewarticle/fda-oks-first-cell-therapy-severe-aplastic-anemia-2025a1000yfl?src=rss